Welcome to LookChem.com Sign In|Join Free

CAS

  • or

100367-55-3

Post Buying Request

100367-55-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

100367-55-3 Usage

Description

2-Cyano-5-nitropyridine is an organic compound characterized by its green solid appearance. It is a derivative of pyridine, a heterocyclic compound, with a nitro group at the 5th position and a cyano group at the 2nd position. 2-Cyano-5-nitropyridine is known for its significant role as a synthetic intermediate in the chemical industry.

Uses

Used in Chemical Synthesis:
2-Cyano-5-nitropyridine is used as a synthetic intermediate for the production of various chemical compounds. Its unique structure allows it to be a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals. The presence of both nitro and cyano functional groups makes it a versatile starting material for further chemical reactions and modifications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Cyano-5-nitropyridine is used as a key intermediate in the synthesis of various drug candidates. Its ability to be modified and functionalized makes it an essential component in the development of new medications with potential therapeutic applications.
Used in Agrochemical Industry:
2-Cyano-5-nitropyridine also finds application in the agrochemical industry, where it is used as a synthetic intermediate for the development of new pesticides and other crop protection agents. Its structural diversity and reactivity contribute to the creation of innovative and effective products for agricultural use.

Check Digit Verification of cas no

The CAS Registry Mumber 100367-55-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,3,6 and 7 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 100367-55:
(8*1)+(7*0)+(6*0)+(5*3)+(4*6)+(3*7)+(2*5)+(1*5)=83
83 % 10 = 3
So 100367-55-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H3N3O2/c7-3-5-1-2-6(4-8-5)9(10)11/h1-2,4H

100367-55-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Nitropicolinonitrile

1.2 Other means of identification

Product number -
Other names 2-Cyano-5-nitropyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:100367-55-3 SDS

100367-55-3Relevant articles and documents

The Synthesis of the High-Potency Sweetener, NC-00637. Part 2: Preparation of the Pyridine Moiety

Ager, David J.,Erickson, Robert A.,Froen, Diane E.,Prakash, Indra,Zhi, Ben

, p. 62 - 71 (2004)

The pyridine moiety within the high-potency sweetener, NC-00637 (1), 5-amino-2-cyanopyridine (4), was prepared from 2-hydroxy-5-nitropyridine (10). The sequence involved the conversion of the hydroxy group to bromide followed by substitution with cyanide to give 2-cyano-5-nitropyridine (8). Reduction of the nitro group proved to be troublesome when catalytic hydrogenation was used. Iron with an acid gave a reproducible reaction that could be used at scale.

QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF

-

Page/Page column 00383, (2017/11/15)

Quinoline compounds are disclosed that have a formula represented by the following: and wherein Cy, R1, R4a, R4b, and n are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, diabetes complications, inflammation, and neurodegeneration, obesity, cancer, ischemia/reperfusion injury, cardiovascular disease and other diseases related to RAGE activity.

NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION

-

Page/Page column 27; 28, (2015/02/25)

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, W and X are as described herein, compositions including the compounds and methods of using the compounds.

COMPOUND HAVING BENZAMIDE SKELETON AND CYCLOOXYGENASE (COX-1)-SELECTIVE INHIBITORY ACTIVITY

-

Page/Page column 11-12, (2009/07/10)

This invention provides a novel COX-1-selective inhibitor. This invention relates to a novel compound represented by the formula below or a salt thereof. This invention also relates to an analgesic agent, an antiinflammatory agent, an antitumor agent, an antiplatelet aggregation agent, and a cyclooxygenase-1-selective inhibitor comprising, as an active ingredient, such compound or salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 100367-55-3